Posted by Michael Wonder on 05 Sep 2024
Adults with von Hippel-Lindau disease to benefit from new treatment
5 September 2024 - NICE has recommended belzutifan for some adults with von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people.
NICE is looking at belzutifan for adults who need treatment for VHL-associated kidney, central nervous system or pancreatic tumours.
